Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Unicycive Therapeutics Inc UNCY

Healthcare Biotechnology
Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being... see more

Bullboard (NDAQ:UNCY)

View:
1 2 Next
Post by whytestockson Sep 20, 2024 10:47am

Life Sciences Virtual Investor Forum Presentations Now Avail

Just In: $UNCY Life Sciences Virtual Investor Forum Presentations Now Available for Online ViewingNEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary ...more  
7
Post by MikeTesteron Aug 03, 2024 4:57am

Unicycive Therapeutics, Inc. (UNCY): Developing Novel Treatm

https://beyondspx.com/2024/08/02/unicycive-therapeutics-inc-uncy-developing-novel-treatments-for-kidney-disease/
25
Post by whytestockson Jun 25, 2024 7:00pm

Unicycive Therapeutics Achieves Study Objective in Oxylantha

Just In: $UNCY Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial@ Successfully Established Favorable Tolerability and Safety of OLC @ @ New Drug ...more  
68
Post by Iseneschalon Mar 10, 2023 12:44pm

UNCY .... thru RBL at $2.63.... on watch still

it better get going.....Me no position
64
Post by Iseneschalon Mar 10, 2023 10:37am

UNCY.....now right in the "thick of res"....$2.50

N>H>O>D.......... All looks good...could go way higher.... I don't know ; ) I just want to say that.... Stops save Portfolios Cheers !
46
Comment by Iseneschalon Mar 10, 2023 9:07am

RE:UNCY .....The trend continues....Day 6 of run....Sheesh

I failed to mention that my chart tells me there congestion at this level.....resistance start at ~ $2.32 Cheers
43
Discussion
Post by Iseneschalon Mar 10, 2023 9:04am

UNCY .....The trend continues....Day 6 of run....Sheesh

Close Prices Last 3 Months Price/volumes not adjusted for restructures Date Ex Sym Open High Low Close Chg ...more  
76
Discussion
Post by Iseneschalon Mar 09, 2023 7:38am

UNCY....ripping in the pre-market open

Volume & price action no position  Cheers !
40
Post by Iseneschalon Mar 07, 2023 9:16am

TRKA ....hmmm all that Rev and still an increase in Net Loss

mainly due to Interest expense was huge....must be a lot of debt.....would it be to the acquisitions See how this plays out No position
52
Post by Iseneschalon Mar 07, 2023 9:12am

TRKA .... ER news

Troika Media Group Inc. Reports Record Revenue of $187.9 million, Adjusted EBITDA of $5.0 million for the Six Months Ended December 31, 2022 Tue Mar 07 09:10:09 2023 EDT Troika Media ...more  
59
1 2 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities